Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Reducing the Receipt of Contraindicated Medications for Patients with Parkinson’s Disease
Movement Disorders
P10 - Poster Session 10 (8:00 AM-9:00 AM)
5-001

Studies have demonstrated that 21-43% of hospitalized PD patients have received dopamine antagonists, leading to complications and longer hospital stays. The AAN has compiled a list of medications that should be avoided in PD.

To reduce the use of contraindicated medications for patients with Parkinson’s disease (PD) seen in Emergency Department (ED) and during hospitalization.

In a retrospective chart review, we identified all PD patients who were hospitalized or seen in the University of Colorado ED from July 1, 2019 to June 30, 2020 for baseline data. We calculated the proportion of these patients who received contraindicated medications. With stakeholder input from movement disorder neurologists, surgeons, pharmacists, inpatient physicians, emergency department (ED) physicians, and electronic medical record (EMR) analysts, we developed an EMR best practice alert (BPA) that was launched on December 8, 2020. The BPA is triggered when a patient with a diagnosis of PD is prescribed a dopamine-blocking medication. We collected data on BPA use and the number of PD patients who received contraindicated medications in the 12 months after the BPA was launched.

At baseline, 19.3% of PD patients at the University of Colorado received at least one dose of a contraindicated medication. In the first 3 months after BPA deployment, 139 PD patients were seen in the ED or admitted to the hospital. The use of contraindicated medications was reduced by 41.5% (19.3% vs 11.3%). Over the 12 months after deployment, 547 PD patients were seen, and contraindicated medication use remained 25.6% lower than baseline. Length of stay was significantly longer for those who received a contraindicated medication at baseline and after the intervention. Involvement of pharmacists was associated with removal of inappropriate orders.

An electronic medical record best practice alert decreased the use of contraindicated medications for PD patients in the hospital setting.
Authors/Disclosures
Caroline Goldin, MD
PRESENTER
Dr. Goldin has nothing to disclose.
Elisa Worledge, Other Mrs. Worledge has nothing to disclose.
Jarrett Bremmer, Other Mr. Bremmer has nothing to disclose.
Kathryn Tremolet De Villers, PharmD (University of Colorado) Dr. Tremolet De Villers has nothing to disclose.
Robbie Cummins, Other (University of Colorado Anschutz Medical Campus) Mr. Cummins has nothing to disclose.
Michelle Fullard, MD (University of Colorado Anschutz) Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.